Semaglutide ndeye glucose-yakadzika mushonga unogadzirwa naNordisk yekurapa kwetudzi 2 chirwere cheshuga. Muna June 2021, iyo FDA yakatenderwa semaglutudide yekushambadzira sehuremu hwekuremesa mushonga (Trade zita wegavy). Mushonga weGlucagon-Senge Cheptide 1 (GLP-1) Receptor Agonist uyo anogona kutevedzera mhedzisiro yacho, kuderedza nzara, uye nekudzikisa kudya kwekudya uye calorie kudya, saka zvinoshanda pakudya uremu.
Pamusoro pekurapa kurapa Type 2 chirwere cheshuga uye kufutisa, semaglutudide yakawanikwa zvakare kuchengetedza hutano hwemakore, kuderedza njodzi yekenza, uye kubatsira kurega kunwa. Uyezve, zvidzidzo zviviri zvapfuura zvakaratidza kuti semaglutudi iyi zvakare inoderedza njodzi yehosha isingaperi chirwere chezvirwere neAlzheimer's chirwere.
Zvidzidzo zvepamberi zvakaratidza kuti kurema uremu kunogona kudzoreredza zviratidzo zvebvi endeoarthritis (kusanganisira zororo rekurwadziwa). Nekudaro, mhedzisiro yeGLP-1 Receptor Agonist uremu kurema mishonga yakadai se semaglutudi pamabvi ebvi ebvu mune vanhu vane simba havana kudzidza zvizere.
Musi waGumiguru 3024, vaongorori vanobva kuyunivhesiti yeCopenhagen neNordisk Burning bepa rekutsvagisa.
Kudzidza uku kwekiriniki kwakaratidza kuti semaglutudi inogona kuderedza zvakanyanya uremu uye zvakanyanya kuderedza marwadzo akakonzerwa nebvi rinoratidzira neyepoodiids), uye kugadzirisa kugona kwavo kutora mitambo. Izvi zvekare kekutanga kuti rudzi rutsva rwemhando yekurema, glp-1 receptor agonist, yakasimbiswa kurapa arthritis.
Kutumira Nguva: Kukadzi-27-2025